Literature DB >> 6971810

Natural killer cell activity in chickens: target cell analysis and effect of antithymocyte serum on effector cells.

J M Sharma, W Okazaki.   

Abstract

A battery of lymphoid and nonlymphoid cells was examined for susceptibility to lysis by natural killer cells of chickens. Several susceptible targets were recognized, and most susceptible among these were cells of line LSCC-RP9, derived from a lymphoid tumor induced by Rous-associated virus 2. The natural killer reactivity against LSCC-RP9 target cells did not appear to be directed against an antigen(s) induced by Rous-associated virus 2 because other lymphoid and nonlymphoid cells infected with this were resistant to lysis in vitro by natural killer cells. The effector cells of natural killer reactivity in chickens were refractory to treatment with potent anti-T-cell and anti-B-cell sera. Inoculation of Marek's disease virus in line 15 X 7 chickens resulted in enhanced natural killer cell activity, and the effector cells of this enhanced activity, and the effector cells of this enhanced activity were also resistant to anti-T-cell serum.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6971810      PMCID: PMC351427          DOI: 10.1128/iai.31.3.1078-1085.1981

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  26 in total

1.  Two cell lines from lymphomas of Marek's disease.

Authors:  Y Akiyama; S Kato
Journal:  Biken J       Date:  1974-09

2.  Evidence for the in vitro transfer of defective Rous sarcoma virus genome from hamster tumor cells to chick cells.

Authors:  P S Sarma; W Vass; R J Huebner
Journal:  Proc Natl Acad Sci U S A       Date:  1966-06       Impact factor: 11.205

3.  Introduction of "natural" killer' cells by BCG.

Authors:  S A Wolfe; D E Tracey; C S Henney
Journal:  Nature       Date:  1976-08-12       Impact factor: 49.962

4.  "Natural" killer cells in the mouse. I. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Specificity and distribution according to genotype.

Authors:  R Kiessling; E Klein; H Wigzell
Journal:  Eur J Immunol       Date:  1975-02       Impact factor: 5.532

5.  Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic tumors. II. Characterization of effector cells.

Authors:  R B Herberman; M E Nunn; H T Holden; D H Lavrin
Journal:  Int J Cancer       Date:  1975-08-15       Impact factor: 7.396

6.  "Natural" killer cells in the mouse. II. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Characteristics of the killer cell.

Authors:  R Kiessling; E Klein; H Pross; H Wigzell
Journal:  Eur J Immunol       Date:  1975-02       Impact factor: 5.532

7.  Natural occurrence of lymphocytes showing cytotoxic activity to BALB/c radiation-induced leukemia RL male 1 cells.

Authors:  F Sendo; T Aoki; E A Boyse; C K Buafo
Journal:  J Natl Cancer Inst       Date:  1975-09       Impact factor: 13.506

8.  Demonstration of a tumor-associated surface antigen in Marek's disease.

Authors:  R L Witter; E A Stephens; J M Sharma; K Nazerian
Journal:  J Immunol       Date:  1975-07       Impact factor: 5.422

9.  Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic acid allogeneic tumors. I. Distribution of reactivity and specificity.

Authors:  R B Herberman; M E Nunn; D H Lavrin
Journal:  Int J Cancer       Date:  1975-08-15       Impact factor: 7.396

10.  In vitro suppression of T-cell mitogenic response and tumor cell proliferation by spleen macrophages from normal chickens.

Authors:  J M Sharma
Journal:  Infect Immun       Date:  1980-06       Impact factor: 3.441

View more
  10 in total

1.  Differential cytokine responses following Marek's disease virus infection of chickens differing in resistance to Marek's disease.

Authors:  Pete Kaiser; Greg Underwood; Fred Davison
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

2.  Isolation and functional characterization of chicken intestinal intra-epithelial lymphocytes showing natural killer cell activity against tumour target cells.

Authors:  J Y Chai; H S Lillehoj
Journal:  Immunology       Date:  1988-01       Impact factor: 7.397

3.  Two class I genes of the chicken MHC have different functions: BF1 is recognized by NK cells while BF2 is recognized by CTLs.

Authors:  Taejoong Kim; Henry D Hunt; Mark S Parcells; Vicky van Santen; Sandra J Ewald
Journal:  Immunogenetics       Date:  2018-06-09       Impact factor: 2.846

Review 4.  Natural killer (NK) cells in domestic animals: phenotype, target cell specificity and cytokine regulation.

Authors:  D L Evans; L Jaso-Friedmann
Journal:  Vet Res Commun       Date:  1993       Impact factor: 2.459

5.  Further studies on the mitogenic and immune-modulating effects of plasminogen activator.

Authors:  M A Wainberg; E Israel; R G Margolese
Journal:  Immunology       Date:  1982-04       Impact factor: 7.397

6.  Natural cell-mediated cytotoxicity of bovine mononuclear cells against virus-infected cells.

Authors:  M Campos; C R Rossi; M J Lawman
Journal:  Infect Immun       Date:  1982-06       Impact factor: 3.441

7.  MHC and non-MHC genetic influences on Rous sarcoma metastasis in chickens.

Authors:  W M Collins; D W Brown; P H Ward; W R Dunlop; W E Briles
Journal:  Immunogenetics       Date:  1985       Impact factor: 2.846

8.  Effect of infectious bursal disease on natural killer cell activity and mitogenic response of chicken lymphoid cells: role of adherent cells in cellular immune suppression.

Authors:  J M Sharma; L F Lee
Journal:  Infect Immun       Date:  1983-11       Impact factor: 3.441

9.  Comparison of different dietary sources of n-3 polyunsaturated fatty acids on immune response in broiler chickens.

Authors:  H Al-Khalaifah; A Al-Nasser; D I Givens; C Rymer; P Yaqoob
Journal:  Heliyon       Date:  2020-01-30

10.  Natural killer cell activity of chicken intraepithelial leukocytes against rotavirus-infected target cells.

Authors:  T J Myers; K A Schat
Journal:  Vet Immunol Immunopathol       Date:  1990-10       Impact factor: 2.046

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.